Siraj Dhanani

Overview

Siraj Dhanani is the founder and CEO of InnAccel, India's first and only Medical Technology Innovation Platform for Global Emerging Markets. InnAccel focuses on developing innovative medical devices tailored for emerging markets, addressing critical healthcare challenges. The company's product portfolio includes VAPCare, an automated secretion management and oral hygiene system; SAANS, a portable neonatal CPAP device; and Fetal Lite, an AI-enabled fetal heart rate monitor. These products aim to improve patient outcomes and healthcare delivery in resource-constrained settings. Prior to founding InnAccel, Siraj established PharmARC, a healthcare marketing analytics and consulting firm, which was acquired by IQVIA. He has also held positions in pharmaceutical marketing at Bristol-Myers Squibb and in healthcare investment banking at UBS in New York City. Siraj holds an MBA in finance and international business from NYU Stern School of Business and a Master's in pharmaceutical marketing and administration from The Ohio State University. Under Siraj's leadership, InnAccel has developed a suite of medical devices that address unmet needs in emerging markets. The company's products have received international recognition, with VAPCare obtaining US FDA approval and patents in multiple countries. InnAccel's mission is to create affordable and effective medical technologies that can be deployed in low-resource settings, thereby improving global health outcomes.